Voyager Therapeutics, Inc.

Historical 13F Holders

Symbol
VYGR
CUSIP
92915B106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 92915B106 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 9
5.6% 8/14/2026
Event 6/30/2026
Integrated Core Strategies (US) LLC 13G/A Amendment 1
7.4% 7/31/2026
Event 6/30/2026
Armistice Capital, LLC 13G/A Amendment 8
5.9% 5/15/2026
Event 3/31/2026
EcoR1 Capital, LLC 13G/A Amendment 7
0% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 5 0% 3/27/2026
Event 3/13/2026
Armistice Capital, LLC 13G/A Amendment 7
7.2% 2/18/2026
Event 12/31/2025
EcoR1 Capital, LLC 13G/A Amendment 6
6.8% 2/17/2026
Event 12/31/2025
Integrated Core Strategies (US) LLC 13G
6.1% 1/26/2026
Event 1/16/2026
Armistice Capital, LLC 13G/A Amendment 6
7.6% 11/14/2025
Event 9/30/2025
EcoR1 Capital, LLC 13G/A Amendment 5
6.8% 11/14/2025
Event 9/30/2025
Armistice Capital, LLC 13G/A Amendment 4
9.9% 5/15/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 2 6.4% 4/24/2025
Event 3/31/2025
Armistice Capital, LLC 13G/A Amendment 3
9.9% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 946 $2.54 k
2026 Q2 144 35.0 M $123 M
2026 Q1 141 33.5 M $129 M
2025 Q4 132 33.8 M $133 M
2025 Q3 123 30.4 M $142 M
2025 Q2 118 33.5 M $104 M
2025 Q1 120 34.7 M $117 M
2024 Q4 137 34.6 M $196 M
2024 Q3 134 35.4 M $207 M
2024 Q2 134 38.9 M $308 M
2024 Q1 141 36.5 M $340 M
2023 Q4 116 27.8 M $235 M
2023 Q3 118 27.3 M $211 M
2023 Q2 111 26.9 M $308 M
2023 Q1 90 23.8 M $184 M
2022 Q4 75 24.1 M $147 M
2022 Q3 75 24.1 M $143 M
2022 Q2 84 24.1 M $142 M
2022 Q1 80 22.5 M $171 M
2021 Q4 69 18.9 M $51.4 M
2021 Q3 73 22.2 M $58.6 M
2021 Q2 84 23.4 M $96.8 M
2021 Q1 108 26.9 M $130 M
2020 Q4 110 27.8 M $199 M
2020 Q3 117 28.2 M $301 M
2020 Q2 120 30.1 M $380 M
2020 Q1 127 30.3 M $277 M
2019 Q4 146 31.3 M $436 M
2019 Q3 138 31.8 M $559 M
2019 Q2 139 29.3 M $797 M
2019 Q1 116 27.5 M $526 M
2018 Q4 120 28.1 M $265 M
2018 Q3 128 29.2 M $552 M
2018 Q2 130 29.1 M $569 M
2018 Q1 113 27.3 M $512 M
2017 Q4 102 25.2 M $418 M
2017 Q3 79 11.3 M $233 M
2017 Q2 52 10.9 M $98.1 M
2017 Q1 49 11.1 M $147 M
2016 Q4 59 12.5 M $160 M
2016 Q3 52 10.6 M $128 M
2016 Q2 48 10.6 M $116 M
2016 Q1 43 10.0 M $87.0 M
2015 Q4 36 10.4 M $225 M